Development of Lipid–Polymer Hybrid Nanoparticles for Improving Oral Absorption of Enoxaparin

Enoxaparin, an anticoagulant that helps prevent the formation of blood clots, is administered parenterally. Here, we report the development and evaluation of lipid–polymer hybrid nanoparticles (LPHNs) for the oral delivery of enoxaparin. The polymer poloxamer 407 (P407) was incorporated into lipid n...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bo, Qian, Yu, Fang, Guihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407632/
https://www.ncbi.nlm.nih.gov/pubmed/32629827
http://dx.doi.org/10.3390/pharmaceutics12070607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7407632/
https://www.ncbi.nlm.nih.gov/pubmed/32629827
http://dx.doi.org/10.3390/pharmaceutics12070607

Ejemplares similares